[Significances of RET fusion gene in non-small cell lung cancer]

Jingjing Liu1, Minghong Bi

  • 1Department of Medical Oncology, the First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.

Insights

RET fusion genes are key targets in non-small cell lung cancer (NSCLC) treatment. Targeting these RET fusions with specific inhibitors offers a promising approach for personalized NSCLC therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Lung cancer remains a leading cause of cancer mortality globally.
  • Molecular targeted therapy is a significant area of research for non-small cell lung cancer (NSCLC).
  • RET fusion genes present distinct clinical and pathological features in specific lung cancer subsets.

Purpose:

  • To review the structural characteristics of RET fusion genes.
  • To examine the expression models of RET fusion genes in clinical samples.
  • To discuss the therapeutic implications of targeting RET fusions in NSCLC.

Summary:

  • RET fusion genes are identified in subsets of NSCLC patients.
  • Effective treatment is achievable using RET inhibitors for tumors with these fusions.
  • This suggests RET fusion genes are a viable target for individualized NSCLC treatment strategies.

Impact:

  • Highlights RET fusion genes as a potential biomarker for personalized NSCLC therapy.
  • Emphasizes the efficacy of RET inhibitors in a specific NSCLC subgroup.
  • Provides insights into the structural and expression patterns of RET fusions relevant to clinical application.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K